Laiba Arshad

943 total citations
28 papers, 709 citations indexed

About

Laiba Arshad is a scholar working on Pharmacology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Laiba Arshad has authored 28 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Molecular Biology and 6 papers in Molecular Medicine. Recurrent topics in Laiba Arshad's work include Curcumin's Biomedical Applications (6 papers), Pharmacological Effects of Natural Compounds (5 papers) and Ginger and Zingiberaceae research (4 papers). Laiba Arshad is often cited by papers focused on Curcumin's Biomedical Applications (6 papers), Pharmacological Effects of Natural Compounds (5 papers) and Ginger and Zingiberaceae research (4 papers). Laiba Arshad collaborates with scholars based in Pakistan, Malaysia and Bangladesh. Laiba Arshad's co-authors include Md. Areeful Haque, Ibrahim Jantan, Syed Nasir Abbas Bukhari, Abdi Wira Septama, Zeti‐Azura Mohamed‐Hussein, Hemavathy Harikrishnan, Mohammad Forhad Khan, Raffaele Capasso, Md. Jakaria and Israt Jahan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Pharmacology and The Journal of Nutritional Biochemistry.

In The Last Decade

Laiba Arshad

24 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laiba Arshad Pakistan 13 207 200 157 117 94 28 709
Supada R. Rojatkar India 17 222 1.1× 324 1.6× 253 1.6× 108 0.9× 38 0.4× 54 882
K. Rajendran India 12 219 1.1× 243 1.2× 362 2.3× 140 1.2× 73 0.8× 31 1.2k
Periyasamy Viswanathan India 12 141 0.7× 137 0.7× 106 0.7× 60 0.5× 26 0.3× 12 671
Kuo‐Hsiung Lee United States 13 108 0.5× 364 1.8× 122 0.8× 63 0.5× 69 0.7× 18 650
Chia-Chung Hou Taiwan 11 172 0.8× 372 1.9× 135 0.9× 226 1.9× 19 0.2× 11 970
A.M. Mujumdar India 17 370 1.8× 248 1.2× 309 2.0× 248 2.1× 54 0.6× 34 951
Jun‐Chih Ou Taiwan 16 197 1.0× 513 2.6× 316 2.0× 78 0.7× 77 0.8× 22 876
S Khozirah Malaysia 11 120 0.6× 254 1.3× 272 1.7× 126 1.1× 55 0.6× 13 751
Amira Abdel Motaal Egypt 22 85 0.4× 494 2.5× 345 2.2× 94 0.8× 84 0.9× 51 1.1k
Chuan‐Li Lu China 17 166 0.8× 324 1.6× 297 1.9× 108 0.9× 20 0.2× 36 754

Countries citing papers authored by Laiba Arshad

Since Specialization
Citations

This map shows the geographic impact of Laiba Arshad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laiba Arshad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laiba Arshad more than expected).

Fields of papers citing papers by Laiba Arshad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laiba Arshad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laiba Arshad. The network helps show where Laiba Arshad may publish in the future.

Co-authorship network of co-authors of Laiba Arshad

This figure shows the co-authorship network connecting the top 25 collaborators of Laiba Arshad. A scholar is included among the top collaborators of Laiba Arshad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laiba Arshad. Laiba Arshad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Arshad, Laiba, Md. Areeful Haque, Hemavathy Harikrishnan, Sarah Ibrahim, & Ibrahim Jantan. (2024). Syringin from Tinospora crispa downregulates pro-inflammatory mediator production through MyD88-dependent pathways in lipopolysaccharide (LPS)-induced U937 macrophages. Molecular Biology Reports. 51(1). 789–789. 5 indexed citations
7.
Arshad, Laiba, et al.. (2022). Frequency of Depression and Suicidal Thoughts in Young Adults of Pakistan: A Cross- Sectional Study. SHILAP Revista de lepidopterología. 3(4). 6–6.
8.
Jantan, Ibrahim, Md. Areeful Haque, Laiba Arshad, et al.. (2021). Dietary polyphenols suppress chronic inflammation by modulation of multiple inflammation-associated cell signaling pathways. The Journal of Nutritional Biochemistry. 93. 108634–108634. 103 indexed citations
10.
Islam, Mohammad Nazmul, Laiba Arshad, Md. Areeful Haque, et al.. (2020). Stem extract of Albizia richardiana exhibits potent antioxidant, cytotoxic, antimicrobial, anti-inflammatory and thrombolytic effects through in vitro approach. SHILAP Revista de lepidopterología. 6(1). 16 indexed citations
11.
Jantan, Ibrahim, et al.. (2019). Standardized ethanol extract, essential oil and zerumbone of Zingiber zerumbet rhizome suppress phagocytic activity of human neutrophils. BMC Complementary and Alternative Medicine. 19(1). 331–331. 21 indexed citations
12.
Jantan, Ibrahim, et al.. (2019). Immunosuppressive effects of the standardized extract of Zingiber zerumbet on innate immune responses in Wistar rats. Phytotherapy Research. 33(4). 929–938. 10 indexed citations
13.
Arshad, Laiba, Ibrahim Jantan, & Syed Nasir Abbas Bukhari. (2019). <p>Enhanced immunosuppressive effects of 3,5-bis[4(diethoxymethyl)benzylidene]-1-methyl-piperidin-4-one, an &alpha;, &beta;-unsaturated carbonyl-based compound as PLGA-<em>b</em>-PEG nanoparticles</p>. Drug Design Development and Therapy. Volume 13. 1421–1436. 2 indexed citations
14.
Jantan, Ibrahim, et al.. (2019). Zerumbone from Zingiber zerumbet inhibits innate and adaptive immune responses in Balb/C mice. International Immunopharmacology. 73. 552–559. 18 indexed citations
15.
Jantan, Ibrahim, et al.. (2019). An Insight Into the Modulatory Effects and Mechanisms of Action of Phyllanthus Species and Their Bioactive Metabolites on the Immune System. Frontiers in Pharmacology. 10. 878–878. 96 indexed citations
16.
Arshad, Laiba, Ibrahim Jantan, Syed Nasir Abbas Bukhari, & Shajarahtunnur Jamil. (2018). Inhibitory effects of α, β-unsaturated carbonyl-based compounds and their pyrazoline derivatives on the phagocytosis of human neutrophils. Medicinal Chemistry Research. 27(5). 1460–1471. 5 indexed citations
17.
Arshad, Laiba, Md. Areeful Haque, Syed Nasir Abbas Bukhari, & Ibrahim Jantan. (2017). An Overview of Structure–Activity Relationship Studies of Curcumin Analogs as Antioxidant and Anti-Inflammatory Agents. Future Medicinal Chemistry. 9(6). 605–626. 72 indexed citations
18.
Arshad, Laiba, Ibrahim Jantan, Syed Nasir Abbas Bukhari, & Md. Areeful Haque. (2017). Immunosuppressive Effects of Natural α,β-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review. Frontiers in Pharmacology. 8. 22–22. 70 indexed citations
19.
Haque, Md. Areeful, Ibrahim Jantan, Laiba Arshad, & Syed Nasir Abbas Bukhari. (2017). Exploring the immunomodulatory and anticancer properties of zerumbone. Food & Function. 8(10). 3410–3431. 60 indexed citations
20.
Hasan, Alamgeer Umme Habiba, Muhammad Naveed Mushtaq, Zahid Khan, et al.. (2016). EVALUATION OF ANTI-DIABETIC EFFECTS OF POLY-HERBAL PRODUCT "DIABETIC BAL" IN ALLOXAN-INDUCED DIABETIC RABBITS.. PubMed. 73(4). 967–974. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026